NCT00870272View on ClinicalTrials.gov

Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)

NACompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Abortion, Induced
Interventions
DRUG

Misoprostol

400mcg misoprostol taken sublingually or buccally

Trial Locations (1)

Unknown

State University of Medicine and Pharmacy, Chisinau

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT00870272 - Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP) | Biotech Hunter | Biotech Hunter